Onconova Therapeutics Inc. (NASDAQ: ONTX) Starts Presentation at NobleCon16
Onconova Therapeutics (NASDAQ: ONTX) is a phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells. Advanced clinical trials with the company’s lead compound, rigosertib, are aimed at what the company believes are unmet medical needs of patients with MDS. Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5…







